Cargando…

Generation of human colon organoids from healthy and inflammatory bowel disease mucosa

Ulcerative colitis and Crohn’s disease are chronic inflammatory bowel diseases (IBD) of unknown cause characterized by a relapsing-remitting behavior. Growing evidence supports the idea that the epithelial barrier plays a central role in the pathogenesis of IBD as well as in its evolution over time,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dotti, Isabella, Mayorgas, Aida, Salas, Azucena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612551/
https://www.ncbi.nlm.nih.gov/pubmed/36301950
http://dx.doi.org/10.1371/journal.pone.0276195
_version_ 1784819797422243840
author Dotti, Isabella
Mayorgas, Aida
Salas, Azucena
author_facet Dotti, Isabella
Mayorgas, Aida
Salas, Azucena
author_sort Dotti, Isabella
collection PubMed
description Ulcerative colitis and Crohn’s disease are chronic inflammatory bowel diseases (IBD) of unknown cause characterized by a relapsing-remitting behavior. Growing evidence supports the idea that the epithelial barrier plays a central role in the pathogenesis of IBD as well as in its evolution over time, thus representing a potential target for novel therapeutic options. In the last decade, the introduction of 3D epithelial cultures from ex vivo-expanded intestinal adult stem cells (ASCs) has impacted our ability to study the function of the epithelium in several gastrointestinal disorders, including IBD. Here, we describe in detail a reproducible protocol to generate Matrigel-embedded epithelial organoids from ASCs of non-IBD and IBD donors using small colonic biopsies, including steps for its optimization. A slightly modified version of this protocol is also provided in case surgical samples are used. With this method, epithelial organoids can be expanded over several passages, thereby generating a large quantity of viable cells that can be used in multiple downstream analyses including genetic, transcriptional, proteomic and/or functional studies. In addition, 3D cultures generated using our protocol are suitable for the establishment of 2D cultures, which can model relevant cell-to-cell interactions that occur in IBD mucosa.
format Online
Article
Text
id pubmed-9612551
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-96125512022-10-28 Generation of human colon organoids from healthy and inflammatory bowel disease mucosa Dotti, Isabella Mayorgas, Aida Salas, Azucena PLoS One Lab Protocol Ulcerative colitis and Crohn’s disease are chronic inflammatory bowel diseases (IBD) of unknown cause characterized by a relapsing-remitting behavior. Growing evidence supports the idea that the epithelial barrier plays a central role in the pathogenesis of IBD as well as in its evolution over time, thus representing a potential target for novel therapeutic options. In the last decade, the introduction of 3D epithelial cultures from ex vivo-expanded intestinal adult stem cells (ASCs) has impacted our ability to study the function of the epithelium in several gastrointestinal disorders, including IBD. Here, we describe in detail a reproducible protocol to generate Matrigel-embedded epithelial organoids from ASCs of non-IBD and IBD donors using small colonic biopsies, including steps for its optimization. A slightly modified version of this protocol is also provided in case surgical samples are used. With this method, epithelial organoids can be expanded over several passages, thereby generating a large quantity of viable cells that can be used in multiple downstream analyses including genetic, transcriptional, proteomic and/or functional studies. In addition, 3D cultures generated using our protocol are suitable for the establishment of 2D cultures, which can model relevant cell-to-cell interactions that occur in IBD mucosa. Public Library of Science 2022-10-27 /pmc/articles/PMC9612551/ /pubmed/36301950 http://dx.doi.org/10.1371/journal.pone.0276195 Text en © 2022 Dotti et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Lab Protocol
Dotti, Isabella
Mayorgas, Aida
Salas, Azucena
Generation of human colon organoids from healthy and inflammatory bowel disease mucosa
title Generation of human colon organoids from healthy and inflammatory bowel disease mucosa
title_full Generation of human colon organoids from healthy and inflammatory bowel disease mucosa
title_fullStr Generation of human colon organoids from healthy and inflammatory bowel disease mucosa
title_full_unstemmed Generation of human colon organoids from healthy and inflammatory bowel disease mucosa
title_short Generation of human colon organoids from healthy and inflammatory bowel disease mucosa
title_sort generation of human colon organoids from healthy and inflammatory bowel disease mucosa
topic Lab Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612551/
https://www.ncbi.nlm.nih.gov/pubmed/36301950
http://dx.doi.org/10.1371/journal.pone.0276195
work_keys_str_mv AT dottiisabella generationofhumancolonorganoidsfromhealthyandinflammatoryboweldiseasemucosa
AT mayorgasaida generationofhumancolonorganoidsfromhealthyandinflammatoryboweldiseasemucosa
AT salasazucena generationofhumancolonorganoidsfromhealthyandinflammatoryboweldiseasemucosa